Docusign (NASDAQ:DOCU) Price Target Raised to $64.00 at Bank of America

Docusign (NASDAQ:DOCUGet Free Report) had its price target hoisted by analysts at Bank of America from $58.00 to $64.00 in a report released on Friday, Benzinga reports. The firm currently has an “underperform” rating on the stock. Bank of America‘s price objective indicates a potential downside of 5.93% from the stock’s current price.

A number of other research analysts have also recently commented on DOCU. UBS Group boosted their price target on Docusign from $54.00 to $70.00 and gave the stock a “neutral” rating in a report on Friday. Piper Sandler reiterated a “neutral” rating and set a $75.00 price objective on shares of Docusign in a research report on Friday. Wells Fargo & Company boosted their target price on shares of Docusign from $55.00 to $60.00 and gave the stock an “equal weight” rating in a report on Friday. Royal Bank Of Canada raised their target price on shares of Docusign from $55.00 to $70.00 and gave the company a “sector perform” rating in a research note on Friday. Finally, Citizens Jmp reiterated a “market outperform” rating and issued a $86.00 price target on shares of Docusign in a report on Friday. Three equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $66.13.

View Our Latest Analysis on Docusign

Docusign Price Performance

Shares of DOCU stock traded up $2.07 on Friday, hitting $68.04. 3,972,474 shares of the stock traded hands, compared to its average volume of 4,102,579. Docusign has a 52 week low of $40.16 and a 52 week high of $86.65. The firm has a 50 day simple moving average of $55.24 and a two-hundred day simple moving average of $49.74. The firm has a market cap of $12.99 billion, a price-to-earnings ratio of 44.03, a PEG ratio of 2.32 and a beta of 0.90.

Docusign (NASDAQ:DOCUGet Free Report) last issued its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.09 by $0.07. The business had revenue of $875.75 million during the quarter, compared to analyst estimates of $867.22 million. Docusign had a return on equity of 17.48% and a net margin of 9.59%.Docusign’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.30 EPS. Sell-side analysts forecast that Docusign will post 2.03 EPS for the current year.

Insider Buying and Selling at Docusign

In other news, Director James Beer sold 450 shares of the firm’s stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $64.02, for a total value of $28,809.00. Following the completion of the sale, the director directly owned 14,586 shares of the company’s stock, valued at $933,795.72. This trade represents a 2.99% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Blake Grayson sold 15,000 shares of Docusign stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $60.00, for a total value of $900,000.00. Following the completion of the transaction, the chief financial officer owned 126,429 shares of the company’s stock, valued at approximately $7,585,740. This trade represents a 10.61% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 90,602 shares of company stock valued at $4,323,749. Corporate insiders own 0.59% of the company’s stock.

Institutional Investors Weigh In On Docusign

Institutional investors have recently made changes to their positions in the company. NewEdge Advisors LLC raised its position in Docusign by 36.4% in the 1st quarter. NewEdge Advisors LLC now owns 9,202 shares of the company’s stock worth $749,000 after purchasing an additional 2,457 shares during the period. Guggenheim Capital LLC boosted its position in shares of Docusign by 6.7% during the second quarter. Guggenheim Capital LLC now owns 11,543 shares of the company’s stock valued at $899,000 after buying an additional 729 shares during the period. State Street Corp grew its stake in shares of Docusign by 3.0% during the second quarter. State Street Corp now owns 8,074,976 shares of the company’s stock valued at $628,960,000 after buying an additional 236,494 shares during the last quarter. Sei Investments Co. grew its stake in shares of Docusign by 60.7% during the second quarter. Sei Investments Co. now owns 40,386 shares of the company’s stock valued at $3,146,000 after buying an additional 15,247 shares during the last quarter. Finally, Treasurer of the State of North Carolina raised its holdings in shares of Docusign by 51.0% in the second quarter. Treasurer of the State of North Carolina now owns 189,178 shares of the company’s stock worth $14,735,000 after buying an additional 63,911 shares during the period. Institutional investors own 77.64% of the company’s stock.

Docusign News Summary

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: DocuSign reported fiscal Q2 revenue of $875.7 million, up 9.4% year over year and above the $867.2 million consensus estimate. Adjusted EPS of $1.16 also exceeded expectations of approximately $1.09, providing evidence of solid operating momentum. DocuSign Announces Second Quarter Fiscal 2027 Financial Results
  • Positive Sentiment: The company raised its fiscal-year revenue, annual recurring revenue and Intelligent Agreement Management outlook, citing growing demand for AI-powered contract tools. Fiscal Q3 revenue guidance of $886 million to $890 million is broadly in line with analyst expectations, reducing near-term execution concerns. DocuSign raises annual forecast as AI-powered contract tools gain traction
  • Positive Sentiment: DocuSign plans to make its Model Context Protocol server available to every AI agent on September 30. Wider access could strengthen the company’s position as an “agreement layer” connecting contracts with enterprise AI workflows and support longer-term growth. Docusign Agreement Layer for the Agentic Enterprise Coming to Every Agent
  • Positive Sentiment: Analysts responded favorably: Citizens JMP reiterated an “outperform” rating with an $86 price target, while UBS raised its target to $70 from $54. Morgan Stanley and BTIG also reportedly increased their targets, supporting investor confidence in the AI strategy.
  • Neutral Sentiment: Technical momentum remains constructive, with DOCU forming a “golden cross” and trading well above its 200-day moving average. However, the shares’ strong recent run may increase sensitivity to profit-taking after earnings.
  • Negative Sentiment: Despite the earnings beat and higher guidance, the stock reversed some early gains during Friday trading. UBS maintained a “neutral” rating and Needham reiterated “hold,” suggesting some investors view the current valuation and future AI benefits as largely reflected in the share price. DocuSign Stock Reverses Early Gains Despite Q2 Beat

Docusign Company Profile

(Get Free Report)

Docusign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, Docusign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, Docusign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

Docusign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Featured Stories

Analyst Recommendations for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.